• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新型糖基功能化聚合物的纳米粒子。

Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.

机构信息

LAQV-REQUIMTE, Department of Chemistry, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2829-516 Caparica, Portugal.

出版信息

Molecules. 2020 Apr 10;25(7):1744. doi: 10.3390/molecules25071744.

DOI:10.3390/molecules25071744
PMID:32290160
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7180923/
Abstract

Polymeric nanoparticles can be used for drug delivery systems in healthcare. For this purpose poly(lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) offer an excellent polymeric matrix. In this work, PLGA and PEG polymers were functionalized with coumarin and carbohydrate moieties such as thymidine, glucose, galactose, and mannose that have high biological specificities. Using a single oil in water emulsion methodology, functionalized PLGA nanoparticles were prepared having a smooth surface and sizes ranging between 114-289 nm, a low polydispersity index and a zeta potential from -28.2 to -56.0 mV. However, for the corresponding PEG derivatives the polymers obtained were produced in the form of films due to the small size of the hydrophobic core.

摘要

聚合物纳米粒子可用于医疗保健中的药物输送系统。为此,聚(乳酸-共-乙醇酸)(PLGA)和聚(乙二醇)(PEG)提供了极好的聚合物基质。在这项工作中,PLGA 和 PEG 聚合物用香豆素和具有高生物特异性的碳水化合物部分(如胸苷、葡萄糖、半乳糖和甘露糖)进行了功能化。使用单一的油包水乳液方法,制备了具有光滑表面和尺寸在 114-289nm 之间、低多分散指数和zeta 电位在-28.2 到-56.0mV 之间的功能化 PLGA 纳米粒子。然而,对于相应的 PEG 衍生物,由于疏水性核心较小,所得到的聚合物以薄膜形式存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/5ce865a789a1/molecules-25-01744-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/5f16371de804/molecules-25-01744-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/c9cfeccda64c/molecules-25-01744-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/241f1011b390/molecules-25-01744-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/97f840f5c88a/molecules-25-01744-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/ea0598434045/molecules-25-01744-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/a48fc03cba9e/molecules-25-01744-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/013b86d46259/molecules-25-01744-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/bc6b7c503e84/molecules-25-01744-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/634199024358/molecules-25-01744-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/a5caaeb8b7b4/molecules-25-01744-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/9f11bb49e34c/molecules-25-01744-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/622608e9597c/molecules-25-01744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/82ebdb428f0a/molecules-25-01744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/9cc1f7dc1b77/molecules-25-01744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/5ce865a789a1/molecules-25-01744-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/5f16371de804/molecules-25-01744-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/c9cfeccda64c/molecules-25-01744-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/241f1011b390/molecules-25-01744-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/97f840f5c88a/molecules-25-01744-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/ea0598434045/molecules-25-01744-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/a48fc03cba9e/molecules-25-01744-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/013b86d46259/molecules-25-01744-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/bc6b7c503e84/molecules-25-01744-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/634199024358/molecules-25-01744-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/a5caaeb8b7b4/molecules-25-01744-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/9f11bb49e34c/molecules-25-01744-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/622608e9597c/molecules-25-01744-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/82ebdb428f0a/molecules-25-01744-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/9cc1f7dc1b77/molecules-25-01744-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a358/7180923/5ce865a789a1/molecules-25-01744-g004.jpg

相似文献

1
Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.基于新型糖基功能化聚合物的纳米粒子。
Molecules. 2020 Apr 10;25(7):1744. doi: 10.3390/molecules25071744.
2
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.载 5-氟尿嘧啶的 PLA/PLGA-PEG-PPG-PEG 嵌段共聚物纳米粒的制备、体外评价及细胞培养研究。
Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.
3
Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.用于递送紫杉烷类化疗药物的多靶向聚乳酸-羟基乙酸共聚物/聚乙二醇纳米颗粒的微流体制备
Methods Mol Biol. 2020;2059:213-224. doi: 10.1007/978-1-4939-9798-5_11.
4
Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.聚乙二醇(PEG)包覆的、黏液惰性纳米颗粒在产生黏液的胃癌细胞系 HGC-27 细胞中的制备、表征和摄取。
J Biomed Nanotechnol. 2013 Dec;9(12):2017-23. doi: 10.1166/jbn.2013.1708.
5
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.聚乙二醇化聚乳酸-羟基乙酸共聚物纳米粒作为蛋白质载体:大鼠体内的合成、制备及生物分布
J Control Release. 2001 Apr 2;71(2):203-11. doi: 10.1016/s0168-3659(01)00218-8.
6
Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.超细微粒聚乙二醇包覆的聚乳酸-共-羟基乙酸通过疏水性表面活性剂辅助的一锅合成法制备,用于生物医学应用。
Nanotechnology. 2011 May 6;22(18):185601. doi: 10.1088/0957-4484/22/18/185601. Epub 2011 Mar 17.
7
Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.聚乙二醇化对 PLGA 纳米颗粒性质、疏水性药物释放和与人血清白蛋白相互作用的影响。
J Pharm Pharmacol. 2019 Oct;71(10):1497-1507. doi: 10.1111/jphp.13147. Epub 2019 Aug 5.
8
Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.基于聚多巴胺的表面修饰用于开发肿瘤周围激活的纳米颗粒。
Pharm Res. 2013 Aug;30(8):1956-67. doi: 10.1007/s11095-013-1039-y. Epub 2013 Apr 23.
9
Micelle-templated, poly(lactic--glycolic acid) nanoparticles for hydrophobic drug delivery.用于疏水性药物递送的胶束模板聚(乳酸-乙醇酸)纳米颗粒
Int J Nanomedicine. 2018 Jan 10;13:351-366. doi: 10.2147/IJN.S142079. eCollection 2018.
10
Cellular delivery of PEGylated PLGA nanoparticles.PEG 化 PLGA 纳米粒的细胞递释。
J Pharm Pharmacol. 2012 Jan;64(1):61-7. doi: 10.1111/j.2042-7158.2011.01376.x. Epub 2011 Nov 24.

引用本文的文献

1
Breaking barriers: Smart vaccine platforms for cancer immunomodulation.突破障碍:用于癌症免疫调节的智能疫苗平台
Cancer Commun (Lond). 2025 May;45(5):529-571. doi: 10.1002/cac2.70002. Epub 2025 Feb 3.
2
A Systematic Review of Nanomedicine in Glioblastoma Treatment: Clinical Efficacy, Safety, and Future Directions.胶质母细胞瘤治疗中纳米医学的系统评价:临床疗效、安全性及未来方向
Brain Sci. 2023 Dec 18;13(12):1727. doi: 10.3390/brainsci13121727.
3
How to Develop Drug Delivery System Based on Carbohydrate Nanoparticles Targeted to Brain Tumors.

本文引用的文献

1
"Click" chemistry in polymeric scaffolds: Bioactive materials for tissue engineering."Click" 化学在聚合支架中的应用:用于组织工程的生物活性材料。
J Control Release. 2018 Mar 10;273:160-179. doi: 10.1016/j.jconrel.2018.01.023. Epub 2018 Jan 31.
2
Metal nanoparticles in dermatology and cosmetology: Interactions with human skin cells.金属纳米粒子在皮肤科和化妆品学中的应用:与人体皮肤细胞的相互作用。
Chem Biol Interact. 2018 Nov 1;295:38-51. doi: 10.1016/j.cbi.2017.06.018. Epub 2017 Jun 19.
3
Synthesis, characterization and liver targeting evaluation of self-assembled hyaluronic acid nanoparticles functionalized with glycyrrhetinic acid.
如何开发基于靶向脑肿瘤的碳水化合物纳米颗粒的药物递送系统。
Polymers (Basel). 2023 May 30;15(11):2516. doi: 10.3390/polym15112516.
4
Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses.阳离子脂质辅助纳米颗粒用于同时递送CD47小干扰RNA和R848以促进抗肿瘤免疫反应。
Front Pharmacol. 2023 Mar 31;14:1142374. doi: 10.3389/fphar.2023.1142374. eCollection 2023.
5
Selectivity of 1--Propargyl-d-Mannose Preparations.1--炔丙基-d-甘露糖制剂的选择性。
Molecules. 2022 Feb 22;27(5):1483. doi: 10.3390/molecules27051483.
6
-derived bioactives-functionalized gold nanoparticles for prevention of obesity through gut microbiota reshaping.源自生物活性物质功能化的金纳米颗粒,通过重塑肠道微生物群预防肥胖。
Mater Today Bio. 2022 Jan 19;13:100204. doi: 10.1016/j.mtbio.2022.100204. eCollection 2022 Jan.
甘草次酸功能化自组装透明质酸纳米粒的合成、表征及肝脏靶向性评价
Eur J Pharm Sci. 2017 Jan 1;96:255-262. doi: 10.1016/j.ejps.2016.09.036. Epub 2016 Sep 28.
4
A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery.含与不含甲氨蝶呤前药功能化的羟基喜树碱药物纳米棒用于药物递送的比较评价
Nanoscale Res Lett. 2016 Dec;11(1):384. doi: 10.1186/s11671-016-1599-y. Epub 2016 Aug 31.
5
Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.香豆素羧酸作为单羧酸转运蛋白1抑制剂:作为潜在抗癌剂的体外和体内研究
Bioorg Med Chem Lett. 2016 Jul 15;26(14):3282-3286. doi: 10.1016/j.bmcl.2016.05.054. Epub 2016 May 19.
6
Nanotechnology: History and future.纳米技术:历史与未来。
Hum Exp Toxicol. 2015 Dec;34(12):1318-21. doi: 10.1177/0960327115603588.
7
New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.新型香豆素衍生物作为强效选择性COX-2抑制剂:合成、抗炎、定量构效关系及分子模拟研究
Arch Pharm (Weinheim). 2015 Dec;348(12):875-88. doi: 10.1002/ardp.201500274. Epub 2015 Oct 13.
8
Carbohydrate-based materials for targeted delivery of drugs and genes to the liver.用于将药物和基因靶向递送至肝脏的碳水化合物基材料。
Nanomedicine (Lond). 2015 Jul;10(14):2263-88. doi: 10.2217/nnm.15.58.
9
Synthetic biodegradable functional polymers for tissue engineering: a brief review.用于组织工程的合成可生物降解功能聚合物:简要综述
Sci China Chem. 2014 Apr 1;57(4):490-500. doi: 10.1007/s11426-014-5086-y.
10
Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.纳米颗粒与血脑屏障:从体外模型迈向治疗意义
Pharm Res. 2015 Apr;32(4):1161-85. doi: 10.1007/s11095-014-1545-6. Epub 2014 Dec 2.